Search

everythinglearnresearchcommunity

for

Search:↓

A specific RNA, circNlgn, contributes to heart damage and scarring caused by the cancer drug doxorubicin.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

Using CRISPR for gene editing in the body is promising but needs better delivery methods to be more efficient and specific.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

The article concludes that advancements in hair cosmetics require dermatologists to stay informed about products and their potential risks, including allergies and higher risks for hairdressers.

Oral valganciclovir improved a patient's skin condition caused by immunosuppression.

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

A man got six skin cancers within a year after a cell transplant for leukemia but was cancer-free 32 months later; skin checks are important post-transplant.

A leukemia patient showed skin peeling similar to kwashiorkor, a severe protein deficiency.

Innovative methods are reducing animal testing and improving biomedical research.

Arteannuin might work against cancer and Alzheimer's by targeting neprilysin.

Jasmonic acid and its derivatives play important roles in plant health and have potential uses in medicine and agriculture.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.

Some new drugs show potential for treating blood cancers but have serious side effects and need more research.

Superficial granulomatous pyoderma is a unique, mild form of skin disease that often heals without strong medication and responds well to milder treatments.

Lignans and neolignans from plants may help protect against various health issues, including cancer and heart disease.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

Cancer can hijack the body's cell repair system to promote tumor growth, and targeting this process may improve cancer treatments.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Iron and zinc levels in hair are not linked to hair loss from chemotherapy.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

The document explains various skin conditions and their treatments.

Itraconazole is potentially effective for treating invasive aspergillosis, but more research is needed.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Transplant success has improved with better immunosuppressive drugs and donor matching.

The Wnt/β-catenin pathway is important for tissue development and has potential in regenerative medicine, but requires more research for therapeutic use.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

Chemotherapy often causes patterned hair loss, with some scalp areas more resistant to hair loss than others.